Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Self-Study Modules - Continuing Education Activities

Self-Study Modules on Tuberculosis 1 - 5

Continuing education (CE) credits are offered free of charge for various professions. In order to receive CE credit, you must complete an exam and course evaluation.

Activity Number
Activity Title/Topic

Self Study on Tuberculosis (Modules 1-5)


Amera Khan, MPH, BA
Health Education Specialist,
Communications, Education,
and Behavioral Studies Branch,

Phil LoBue, MD, BA
Associate Director for Science,

Lilia Manangan, MPH, BSN
Epidemiologist, Surveillance, Epidemiology,
& Outbreak Investigations Branch,



Renewal Dates

September 1, 2013/September 1, 2015



Not Applicable



Target Audience:

Physicians, Registered Nurses, Certified Health Educators, Epidemiologists, Medical Assistants, Medical Students, Nurse Practitioners, Nurse Technicians, Other Health Educators, Physician Assistants, Program Managers, Licensed Practical/Vocational Nurses


The target audience for this course is entry- level public health workers who have little or no background in tuberculosis.



Program Description

Modules are designed provide specific TB programmatic information for health care staff who work on the frontlines of TB prevention and control in a self-study format.


At the conclusion of the session, the participant will be able to:

  • Discuss Module 1: Transmission and Pathogenesis of Tuberculosis

    1. Describe the history of TB.
    2. Explain how TB is spread (transmission).
    3. Define drug-resistant TB.
    4. Explain the difference between latent TB infection (LTBI) and TB disease.
    5. Explain how LTBI and TB disease develop (pathogenesis).
    6. Describe the classification system for TB.
  • Discuss Module 2: Epidemiology of Tuberculosis

    1. Describe how the number of TB cases reported in the United States has changed over the last 50 years.
    2. List five factors that contributed to the increase in the number of TB cases between 1985 and 1992.
    3. List three improvements TB programs were able to make with increased federal funds that have contributed to a decrease in TB cases since 1993.
    4. List the groups of people who are more likely to be exposed to or infected with Mycobacterium tuberculosis.
    5. List the groups of people who are more likely to develop TB disease once infected with M. tuberculosis.
  • Discuss Module 3: Diagnosis of Tuberculosis Infection and Disease

    1. Identify high-risk groups for targeted testing.
    2. Describe how to place, read, and interpret a Mantoux tuberculin skin test.
    3. Describe how to interpret a QuantiFERON-TB Gold test.
    4. Discuss considerations (for example, false-positives, false-negatives and/or limitations) for using either the tuberculin skin test or the QuantiFERON-TB Gold test for diagnosing infection with Mycobacterium tuberculosis.
    5. Describe the components of a medical evaluation for diagnosing TB disease.
  • Discuss Module 4: Treatment of Tuberculosis Infection and Disease

    1. List the groups of people who should receive high priority for LTBI treatment.
    2. Describe treatment regimens for LTBI disease.
    3. Describe treatment regimens for TB disease.
    4. Describe the principles of preventing drug resistance.
    5. Describe patient monitoring during LTBI and TB disease treatment.
    6. Describe TB treatment adherence strategies.
    7. List the common adverse reactions to the drugs used to treat LTBI and TB disease.
  • Discuss Module 5: Infectiousness and Infection Control

    1. Describe the factors that determine the infectiousness of a TB patient.
    2. Describe the main goals of a TB infection control program.
    3. Describe the three levels of control measures that are the basis of an effective infection-control program.
    4. Describe the purpose and the characteristics of a TB airborne infection isolation room.
    5. Describe the circumstances when personal respirators should be used.

Contact Information

Division of Tuberculosis Elimination

Accreditation Statements

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this enduring for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides 6.3 contact hours.

CEU: The CDC has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102. The CDC is authorized by IACET to offer 0.6 ANSI/IACET CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 6.5 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number GA0082

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, content experts,and their spouses/partnerswish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

Contentwill not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC does not accept commercial support.

Method Of Participation

You may participate in the educational activity by viewing the program information above.

To evaluate this educational activity, receive a certificate/statement of credit/contact hours, to print-out an on-going transcript of all your TCEOnline CE activities for credits/contact hours, please go to:


No fees are charged for CDC’s CE activities.

Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30329
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC–INFO
  • Page last reviewed: August 23, 2013
  • Page last updated: August 23, 2013 The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO